The lack of testing for COVID-19 is stunting outbreak management. There are limited testing kits for RT-PCR, and even when testing kits are available, the results have variations and false positives. But there’s an alternative: chest CT scans can be faster and more accurate. So the team behind M-VIC19 created an AI diagnosis tool to help doctors and radiologists automatically detect infected areas inside the lungs. Unlike testing for RT-PCR, diagnosis with chest scans can help doctors pinpoint exactly where in the lungs the infection has taken hold. And they’re getting great results: The vision imaging tests have been 89% accurate on real-world corona patients.
“We wanted to build an AI solution that could help doctors and radiologists save some time and get results quicker,” says Sonu Kumar, a co-founder of McMarvin. “AI is one of the most important things that can help us battle this pandemic. AI is so fast and so good that it takes a couple of minutes to do a computation that, for a human, would take 10-20 years.”
McMarvin also built a centralized database to keep record of suspected cases COVID-19, which will help researchers learn about the disease using real-world data. “The only thing that matters right now is fighting COVID-19,” says Kumar. “We are trying to give our 100% to build something that could fight the pandemic.”
What’s next: The project is very close to getting seed funding, which would allow the team to build an all-in-one medical imaging platform for detecting and segmenting all respiratory diseases. In the meantime, McMarvin is continuing research by getting additional data on corona-infected patients to make their platform more accurate and robust.
Terminal donated 1,000 USD on McMarvin’s behalf to PM-CARES, which funds treatment and research for COVID-19 in India.